• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of September 12, 2012

  • Print
  • Share
  • E-mail

Product Detail

Product Description Red Blood Cells Leukocytes Reduced
Recall Number B-2192-12
Classification Class III
Code Info 024FJ24130; 024FJ24132; 024FJ24133; 024FJ24134; 024FJ24139; 024FJ24144; 024GL69697; 024GL69704; 024KC60837; 024KG92957; 024KG92963;024KG92978; 024KG92981; 024KG92983; 024KQ99617;024KQ99618; 024KQ99620, 024KG92580, 024KS00234, 024FL27016, 024FT14085, 024GL69657, 024GY45090, 024GY45096, 024GY45100, 024KY02545, 024KY02577, 024FJ24139, 024GK72339, 024KE82978, 024KG92974, 024KG92963, 024KP1666, 024KQ99618, 024KY02731, 024KY02732, 024KY02739, 024GP05065, 024GP05067, 024KJ12425, 024KZ65305.
Product Distributed Qty 41 units
Reason For Recall Blood products, which may have reached an unacceptable temperature during storage, were distributed.

Event Detail

Event Id 55592
Product Type Biologics
Status Terminated
Recalling Firm American National Red Cross (The)
City Louisville
State KY
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-03-02
Initial Firm Notification of Consignee or Public Telephone
Distribution Pattern Kentucky, Indiana, and Illinois.